1. A rule about evidence
Most licensing rules tell a business what to do. This one also says what will be assumed if the business cannot show that it did it. The query takes a few minutes on the Board of Pharmacy's website. What the rule turns on is the word "documented": a query that was run and not recorded leaves the buyer where it would be had no query been run.
The rule matters to clinics and med spas for a reason that sits in a different section of the Revised Code, taken up in section 3 below. A practice owned by prescribers is ordinarily exempt from the terminal distributor license. It loses that exemption for compounded drugs.
2. The text
Paragraph (A) states the duty. "Before a terminal distributor of dangerous drugs may purchase dangerous drugs at wholesale, the terminal distributor shall query the board's online roster (available on the board's website: www.pharmacy.ohio.gov) to confirm any of the following." Two things may be confirmed. The seller is licensed to sell dangerous drugs under section 4729.52 of the Revised Code, or the seller is licensed to make an occasional sale at wholesale under rule 4729:5-3-09.
Paragraph (B) has two sentences, and they do different work.
The first creates a presumption. "If no documented query is conducted before a purchase is made, it shall be presumed that the purchase of dangerous drugs by the terminal distributor is in violation of section 4729.51 of the Revised Code."
The second protects a buyer who can show the query. "If a licensed terminal distributor of dangerous drugs conducts a documented query at least annually and relies on the results of the query in purchasing dangerous drugs, the terminal distributor shall be deemed not to have violated section 4729.51 of the Revised Code in making the purchase."
Three conditions sit inside that protection. The query is documented. It is repeated at least once a year. The buyer relies on its result, which we read to mean that the purchase is made from the seller the query returned as licensed.
3. Who is a terminal distributor
Section 4729.541 of the Revised Code lists the persons exempt from the terminal distributor license. The first three entries cover most independent practices: a licensed prescriber, a business entity whose sole shareholder is a prescriber, and a professional entity in which every owner is a prescriber.
Division (C) then withdraws the exemption for two classes of drug. Any of those persons "shall hold a license as a terminal distributor of dangerous drugs in order to possess, have custody or control of, and distribute" either of the following: "Dangerous drugs that are compounded or used for the purpose of compounding", or a controlled substance in schedules I to V.
A clinic or med spa that keeps compounded preparations on its premises is therefore a terminal distributor for those drugs, whatever its ownership. Rule 4729:5-3-04 applies to it as it applies to a pharmacy.
4. The statute the presumption points to
The presumption is that the purchase violated section 4729.51. Division (F) of that section is the provision a buyer is most likely to have in view. A licensed terminal distributor shall not purchase dangerous drugs "from any person other than a licensed manufacturer, outsourcing facility, third-party logistics provider, repackager, or wholesale distributor", with two exceptions. One permits "occasional purchases" of drugs sold as occasional sales. The other permits transfers between a distributor's own licensed locations.
The first exception is narrower than its name suggests. Rule 4729:5-3-09 defines an occasional sale as "a wholesale sale of a commercially manufactured dangerous drug" that meets the definition of an exempted transaction, made by a pharmacy or another listed seller. For a pharmacy, the dosage units sold this way "shall not exceed five per cent of the total dosage units dispensed by the pharmacy during the same calendar year."
We read the words "commercially manufactured" to leave a compounded preparation outside the occasional sale. If that reading is right, a practice that buys compounded drugs for use in the office is buying from a seller that must hold one of the licenses division (F) names, and an outsourcing facility is on that list. This is our reading of the text. We have not confirmed it with the Board, and a practice that depends on it should.
5. The record that satisfies the rule
The rule requires a documented query and does not prescribe a form. The following is our practice, and is not a statement of what the Board requires.
| Element | What is kept |
|---|---|
| The seller | The legal name and license number exactly as the roster returns them, beside the name on the seller's invoice |
| The result | A dated capture of the roster page showing the license type and its status |
| The person | Who ran the query |
| The date | The day of the query, which must fall before the purchase it supports |
| The repeat | A new capture at least once every twelve months for each seller still in use |
| The reliance | The purchase order or invoice, filed with the capture it rests on |
Two points of practice follow from the text. The capture should be made before the first order, because the presumption attaches to a purchase made with no documented query before it. And the name on the invoice should be compared with the name on the roster, because a query of the wrong entity documents nothing about the seller that shipped.
6. What the rule does not reach
The rule governs purchases at wholesale. A preparation dispensed by a pharmacy on a prescription for a named patient is a dispensing transaction, and the rule's text does not address it.
The rule confirms a license. It says nothing about the lot. A seller that holds the correct license on the day of the query may still ship a preparation whose certificate of analysis does not match the lot number on the vial, and the query will not show it.
The rule is Ohio's. We have not surveyed other states for this paper, and a practice outside Ohio should read its own board's rules.
7. Limits of this paper
This paper is a reading of public text and is not legal advice. Quotations are from the Ohio Administrative Code and the Ohio Revised Code as published on codes.ohio.gov on November 18, 2026. Section 3's conclusion and section 4's reading of "commercially manufactured" are our inferences from that text.
Sources
- Ohio Administrative Code 4729:5-3-04, "Verification of licensure prior to sale or purchase", effective May 19, 2025, paragraphs (A) and (B).
- Ohio Revised Code 4729.51, "Selling, purchasing, distributing, or delivering dangerous or investigational drugs", effective August 26, 2026, division (F).
- Ohio Revised Code 4729.541, "Exemption from licensure as terminal distributor of dangerous drugs", effective October 9, 2026, divisions (A) and (C).
- Ohio Administrative Code 4729:5-3-09, "Occasional sale and drug transfers", effective May 1, 2025, paragraphs (A) and (B).
A practice that wants its sellers checked against the roster and the result kept on file can start with a free supplier check.
We review documents. We do not test material.